Skip to main content
. Author manuscript; available in PMC: 2014 Jul 23.
Published in final edited form as: Bone Marrow Transplant. 2011 May 23;47(4):494–498. doi: 10.1038/bmt.2011.114

Table 3.

Multivariate analysis for outcomes of following RIC HCT for AML and MDS in older patients

Outcome Relative risk for UCB
(95% confidence intervals)1 		P-value
Overall survival 1.31 (0.75–2.29) 0.34
Leukemia-free survival 1.23 (0.73–2.09) 0.44
Relapse 0.66 (0.33–1.30) 0.23
Treatment related mortality 1.22 (0.56–2.67) 0.61
1

Referent – matched sibling donors